| Koba Resources Limited (KOB) ORDINARY FULLY PAID |
Materials |
$12 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Oct 2025 9:27AM |
$0.070 |
$0.060 |
fallen by
14.29%
|
|
KOB - Price-sensitive ASX Announcement
Full Release
Key Points
- Acquisition of Stannary Hills and Mt Garnet Tin-Tungsten Projects.
- Discovery of a new uranium prospect at the Yarramba Project.
- Completion of an $844,000 equity financing.
- Net cash from operating activities was a loss of $186,000.
- Cash at the end of the quarter totaled $1.4 million.
- Implementation of strategic exploration activities across acquired assets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bounty Oil & Gas NL (BUY) ORDINARY FULLY PAID |
Energy |
$5 |
Quarterly Activities Report & App 5B - September 2025
|
31 Oct 2025 9:27AM |
$0.003 |
$0.003 |
fallen by
0%
|
|
BUY - Price-sensitive ASX Announcement
Full Release
Key Points
- Bounty Oil & Gas NL reported a quarterly oil revenue of $272,000 from the Naccowlah Block.
- The company's oil reserves in Queensland increased to 413,000 barrels due to Surat Basin acquisitions and other projects.
- Bounty anticipates commencing oil production in the Surat Basin in early 2026, expected to significantly increase revenue.
- Bounty is involved in legal proceedings regarding the PEP 11 Offshore Sydney Basin project, with a court hearing scheduled for February 2026.
- The company's cash flow from operations showed a net decrease, with a cash balance of $611,000 at the end of the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Hammer Metals Limited (HMX) ORDINARY FULLY PAID |
Materials |
$23 |
Follow-up Drilling Planned at Bronzewing South Gold Project
|
31 Oct 2025 9:26AM |
$0.031 |
$0.026 |
fallen by
16.13%
|
|
HMX - Price-sensitive ASX Announcement
Full Release
Key Points
- Hammer Metals Limited (HMX) is planning a follow-up drilling program at the Bronzewing South Gold Project.
- The follow-up program includes Reverse Circulation (RC) and diamond drilling, with RC drilling expected to resume in late November.
- Recent drilling results suggest potential for a significant gold system in the area, particularly between the Eastern and Central Target zones.
- The team is encouraged by findings that indicate a large-scale gold system might be present.
- Eleven holes were drilled over 2,755 meters, and significant intercepts have been compiled.
- The Boundary East Target Zone remains highly prospective despite only returning anomalous gold levels in recent assays.
- Further drilling is planned to explore high-potential corridors and target zones.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Constellation Resources Limited (CR1) ORDINARY FULLY PAID |
Materials |
$14 |
September 2025 Quarterly Report
|
31 Oct 2025 9:26AM |
$0.200 |
$0.175 |
fallen by
12.50%
|
|
CR1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Constellation holds nine Special Prospecting Authorities covering 87,602 km².
- Natural hydrogen projects are in proximity to the Goldfields Gas Pipeline.
- Positive results from CSIRO studies on hydrogen, helium, and associated gases.
- Ularring Copper Gold Project identified new Cu-Au soil anomalies.
- Exploration Incentive Scheme grant awarded for drilling at Ularring.
- Raised $2.1 million through a non-renounceable entitlement offer.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Vanadium Limited (AVL) ORDINARY FULLY PAID |
Materials |
$1,907 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Oct 2025 9:24AM |
$0.011 |
$0.220 |
risen by
1,900%
|
|
AVL - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of Phase 2 feasibility study for Australian Vanadium Project.
- Regulatory approvals obtained for processing facility at Tenindewa.
- Net cash outflows from operating and investing activities.
- Manufacturing expansion for vanadium electrolyte.
- Strategic engagements with government and industry stakeholders.
- VSUN Energy's involvement in utility-scale energy storage projects.
- Participation in international standards development for vanadium flow batteries.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| NGX Limited (NGX) ORDINARY FULLY PAID |
Materials |
$12 |
September 2025 Quarterly Report
|
31 Oct 2025 9:24AM |
$0.155 |
$0.135 |
fallen by
12.90%
|
|
NGX - Price-sensitive ASX Announcement
Full Release
Key Points
- NGX Limited presented its Quarterly Report for the period ending 30 September 2025.
- The company focuses on developing a portfolio of minerals critical for the clean energy transition.
- NGX continued to assess the development pathway for the Malingunde Project, leveraging its saprolite-hosted graphite advantages.
- There is ongoing exploration of high-grade titanium mineralisation across Malingunde, Msinja, and Lifidzi projects.
- NGX engaged with multiple customers for potential strategic partnerships and future sales agreements.
- The US imposed preliminary anti-dumping duties on anode-grade graphite from China, affecting market dynamics.
- Permitting progress continued for uranium exploration projects in Namibia, with ECC pending final approval.
- NGX is in a strong financial position with approximately $3.3 million in cash and no debt as of 30 September 2025.
- The company is exploring additional opportunities in clean energy and critical minerals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Latitude Group Holdings Limited (LFS) ORDINARY FULLY PAID |
Financials |
$1,175 |
Update - Notification of buy-back - LFSPA
|
31 Oct 2025 9:24AM |
$1.140 |
$1.130 |
fallen by
0.88%
|
|
| Omni Bridgeway Limited (OBL) ORDINARY FULLY PAID US PROHIBITED |
Financials |
$444 |
Investment Portfolio Report at 30 September 2025
|
31 Oct 2025 9:24AM |
$1.590 |
$1.535 |
fallen by
3.46%
|
|
OBL - Price-sensitive ASX Announcement
Full Release
Key Points
- Omni Bridgeway Limited reported a strong first quarter investment performance for the three months ending 30 September 2025.
- The company achieved total cash investment proceeds of A$136.6 million, excluding management fees and carried interest.
- Management fees for the quarter amounted to A$8.6 million.
- The quarter saw 18 investment completions, delivering a multiple-on-invested-capital (MOIC) of 2.8x.
- New commitments reached A$70.2 million with a fair value addition of A$72.8 million.
- A total of 30 exclusive term sheets were agreed upon, representing potential commitments of A$317.8 million.
- OBL-only cash and receivables stood at A$150.0 million, aligning with expectations.
- Operational expenditures are tracking below the FY26 target of A$80 million.
- The Westgem adverse cost liability was settled slightly below provision, with payments spread over FY26 and FY27.
- Funds 4/5 Series II fund capital raise is progressing well, with several new investor commitments secured.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Immuron Limited (IMC) ORDINARY FULLY PAID |
Health Care |
$18 |
Clinical Trial Update
|
31 Oct 2025 9:23AM |
$0.087 |
$0.065 |
fallen by
25.29%
|
|
IMC - Price-sensitive ASX Announcement
Full Release
Key Points
- Immuron Limited is focused on infectious disease treatments with targeted polyclonal antibodies.
- Travelan® is an oral therapy developed to prevent travelers’ diarrhea.
- Clinical trials for Travelan® have shown high efficacy in preventing diarrhea.
- IMM-529 is under development for preventing and treating Clostridioides difficile infections.
- IMM-529 IND application is currently under review by the FDA.
- Clinical trial data release has been delayed due to a government shutdown.
- Travelan® dosing strategy depends on upcoming clinical trial results.
- Immuron’s developments are significant for future regulatory approvals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Verity Resources Limited (VRL) ORDINARY FULLY PAID |
Materials |
$7 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Oct 2025 9:23AM |
$0.018 |
$0.018 |
fallen by
0%
|
|
VRL - Price-sensitive ASX Announcement
Full Release
Key Points
- Successful Phase 1 drilling at Monument Gold Project in Western Australia.
- Completion of the acquisition of joint venture interest in Botswana, achieving 100% ownership.
- Financing activities raised $1.554 million during the quarter.
- Cash at the end of the period was $1.339 million.
- Exploration expenditures totaled $955,758.
- Commitments received for a $3 million placement to support future activities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| NewPeak Metals Limited (NPM) ORDINARY FULLY PAID |
Materials |
$7 |
Quarterly Activities and Cashflow Reports
|
31 Oct 2025 9:23AM |
$0.024 |
$0.020 |
fallen by
16.67%
|
|
NPM - Price-sensitive ASX Announcement
Full Release
Key Points
- NewPeak Metals Limited secured 100% of the Las Opeñas exploration permits, with drilling planned for Q1/Q2 2026.
- The acquisition of the remaining 49% of Las Opeñas permits was completed for US$500,000.
- Preparations for drilling at the Tansey Gold Project are underway, targeting Q4 2025/Q1 2026.
- The company reported a cash balance of $3.5 million, with a low dilution risk.
- Directors and management purchased over 27 million shares, signaling confidence in upcoming exploration activities.
- The Treuer Range Uranium Project in Australia is under review following recent surface sampling results.
- Exploration activities included internal reviews and re-mapping of key project areas.
- NewPeak focuses on strategic investments in Argentina and Australia, with significant exploration potential.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Elixinol Wellness Limited (EXL) ORDINARY FULLY PAID |
Consumer Staple |
$4 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Oct 2025 9:23AM |
$0.015 |
$0.010 |
fallen by
33.33%
|
|
EXL - Price-sensitive ASX Announcement
Full Release
Key Points
- Elixinol Wellness Limited reported a net cash outflow from operating activities of $1.271 million for the quarter ending 30 September 2025.
- The company raised $2.5 million in a two-tranche capital raise, with the first tranche of $632,000 received in Q3 2025.
- Cash and cash equivalents at the end of the quarter were reported at $372,000.
- Elixinol Wellness established several finance facilities, including a $1.35 million secured debt facility and various Shopify Commerce Finance facilities.
- The company's gross margin improved by 300 basis points in Q3 2025 compared to Q2, driven by a shift towards higher-margin e-commerce and core brands.
- Operational cost reductions were implemented across staffing, marketing, and overheads, with expected further savings in Q4.
- Elixinol Wellness is expanding in the high-growth, high-margin wellness segment with new product launches like Protein Water and Metabolic Burn.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Terrain Minerals Limited (TMX) ORDINARY FULLY PAID |
Materials |
$15 |
Proposed issue of securities - TMX
|
31 Oct 2025 9:22AM |
$0.006 |
$0.005 |
fallen by
16.67%
|
|
| Terrain Minerals Limited (TMX) ORDINARY FULLY PAID |
Materials |
$15 |
Placement
|
31 Oct 2025 9:22AM |
$0.006 |
$0.005 |
fallen by
16.67%
|
|
TMX - Price-sensitive ASX Announcement
Full Release
Key Points
- Placement raised $1,173,750.07 at $0.0045 per share.
- GBA Capital acted as Lead Broker.
- Funds to advance exploration at Smokebush Project.
- High-grade gold and silver targeted at Lightning Prospect.
- Placement shares issued under ASX Listing Rule 7.1A.
- Trading halt lifted on 28 October 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Alpha HPA Limited (A4N) ORDINARY FULLY PAID |
Materials |
$825 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Oct 2025 9:22AM |
$0.785 |
$0.725 |
fallen by
7.64%
|
|
A4N - Price-sensitive ASX Announcement
Full Release
Key Points
- Major concrete works and equipment progress for HPA First Project Stage 2.
- Strong demand from semiconductor sector for thermal fillers with zero U/Th content.
- Three new Letters of Intent signed within the semiconductor sector.
- Nano-alumina slurry development for CMP nearing completion.
- High volume manufacturing of alumina dispersion expected by March 2026.
- Net cash decrease primarily due to investments in property, plant, and equipment.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ASF Group Limited (AFA) ORDINARY FULLY PAID |
Financials |
$43 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Oct 2025 9:22AM |
$0.350 |
$0.054 |
fallen by
84.57%
|
|
AFA - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash use of $438,000 in operating activities.
- Net cash inflows of $1.582 million from investing activities.
- Ending cash balance of $2.437 million.
- Payments to related parties totaled $237,000.
- Principal investments include ActivEX Limited and Rey Resources Limited.
- Operations in property marketing and fund management.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Alcidion Group Limited (ALC) ORDINARY FULLY PAID |
Health Care |
$141 |
Notification of cessation of securities - ALC
|
31 Oct 2025 9:21AM |
$0.094 |
$0.105 |
risen by
11.70%
|
|
| Larvotto Resources Limited (LRV) ORDINARY FULLY PAID |
Materials |
$623 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Oct 2025 9:21AM |
$1.030 |
$1.205 |
risen by
16.99%
|
|
LRV - Price-sensitive ASX Announcement
Full Release
Key Points
- Final Investment Decision approved for Hillgrove Antimony-Gold Project.
- Successful completion of US$105M bond and A$70M equity raising.
- Hillgrove Project is a top 10 global antimony deposit.
- Significant high-grade drill results reported.
- Robust financial position with substantial cash inflows.
- Processing plant upgrade commenced.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Artemis Resources Limited (ARV) ORDINARY FULLY PAID |
Materials |
$36 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Oct 2025 9:21AM |
$0.010 |
$0.010 |
fallen by
5%
|
|
ARV - Price-sensitive ASX Announcement
Full Release
Key Points
- Artemis commenced an 18-hole RC drilling program at Karratha Project focused on Titan prospect.
- Encouraging initial results from RC drilling at Titan East indicated 5m @ 13.1g/t gold.
- Board changes included the transition of key executives and the appointment of new company secretaries.
- Capital raising efforts were successful, securing A$4.925 million.
- No tenements were acquired or disposed of during the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Blue Star Helium Limited (BNL) ORDINARY FULLY PAID |
Energy |
$23 |
Galactica Development Production Update
|
31 Oct 2025 9:21AM |
$0.006 |
$0.007 |
risen by
8.33%
|
|
BNL - Price-sensitive ASX Announcement
Full Release
Key Points
- Construction has begun on the Galactica production facility pad and gathering system.
- First production is on schedule for December 2025.
- The project is a joint venture with Helium One Global Ltd, holding a 50% working interest.
- The gathering system starts at Jackson 31 well location, connecting to the Pinon Canyon Plant site.
- The project aims to deliver first helium in December 2025 and first carbon dioxide for sale in H1 2026.
- The development plan is progressing as per the schedule with local community support.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tasman Resources Limited (TAS) ORDINARY FULLY PAID |
Materials |
$8 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Oct 2025 9:21AM |
$0.026 |
$0.024 |
fallen by
7.69%
|
|
TAS - Price-sensitive ASX Announcement
Full Release
Key Points
- Tasman Resources Ltd is working on the Lake Torrens Project in South Australia in partnership with Fortescue.
- During the quarter, Fortescue completed a Magnetotelluric (MT) survey over the Titan and Bill’s Lookout prospect areas.
- Plans for drilling six identified targets at Parkinson Dam were confirmed, focusing on IOCG, epithermal, and porphyry mineralisation.
- Tasman Resources announced a capital raise of $2 million through a two-tranche share placement to support exploration activities.
- Tasman deconsolidated its financial accounts with Eden Innovations Ltd as its shareholding reduced below 19%.
- The company has secured a $57,000 loan, which is unsecured with an interest rate of 9.97% per annum.
- Tasman's cash and cash equivalents at the end of the quarter were $1,000, down from $197,000 at the beginning of the period.
- Corporate activities include the appointment of Mr Louis Varrasso as a non-executive Director and a review of new exploration opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Anagenics Limited (AN1) ORDINARY FULLY PAID |
Consumer Staple |
$2 |
Appendix 4C & Activity Report for Q1 FY2026
|
31 Oct 2025 9:20AM |
$0.005 |
$0.005 |
fallen by
0%
|
|
AN1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Anagenics Limited reported a significant improvement in operating cash outflows during Q1 FY2026, reducing from $0.9 million to $0.3 million.
- The improvement in cash flows was due to reductions in staff and director costs, advertising and marketing costs, and administration and corporate costs.
- The company's restructuring, completed in late 2024/early 2025, led to these financial improvements.
- BLC Cosmetics, a subsidiary of Anagenics, is performing well post-restructure and is exploring new product additions.
- York Street Brands launched Bouf Haircare in May 2025, which is performing above expectations and is projected to achieve over $9 million in sales.
- York Street Brands is considering international market expansion to increase royalty revenues in FY2026.
- Anagenics' directors believe the company has sufficient funds to maintain operations for the next two quarters without additional equity funding.
- The company is actively seeking value-accretive opportunities in line with its strategic objectives.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Great Divide Mining Ltd (GDM) ORDINARY FULLY PAID |
Materials |
$15 |
Quarterly Activities and Cashflow Reports
|
31 Oct 2025 9:20AM |
$0.340 |
$0.340 |
fallen by
0%
|
|
GDM - Price-sensitive ASX Announcement
Full Release
Key Points
- Great Divide Mining Ltd (GDM) achieved its first gold pour at the Challenger Gold Mine, marking a transition to production.
- Ownership in Challenger Mines Pty Ltd increased to 51% under the Adelong Venture.
- Aiming for production of 500 oz/month in FY2026, expanding to 20,000 oz annually.
- Strong investor support with $1.335 million raised via convertible loan offer.
- Focused on sustainability initiatives like water recycling and community partnerships.
- Adelong Venture's 1st Annual Plan set production and expansion objectives amid joint venture disputes.
- Joint ventures and exploration projects continued, notably at Coonambula and Devil's Mountain.
- Corporate efforts included capital raising and managing tenement holdings.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cann Group Limited (CAN) ORDINARY FULLY PAID |
Health Care |
$9 |
Shareholder update webinar
|
31 Oct 2025 9:20AM |
$0.012 |
$0.009 |
fallen by
25%
|
|
| Celsius Resources Limited (CLA) ORDINARY FULLY PAID |
Materials |
$36 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Oct 2025 9:19AM |
$0.012 |
$0.011 |
fallen by
8.33%
|
|
CLA - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly report for period ending 30 September 2025.
- MCB Project advancing with ongoing feasibility and engineering studies.
- Financial support from Maharlika Investment Corporation.
- Closing cash balance of A$2.39 million as of the end of the quarter.
- Community and environmental management efforts underway.
- Company actively engaging investors for further funding solutions.
- Significant assay results from drilling reaffirm project potential.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
